Puerarin clinical trials
How each study uses puerarin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the puerarin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Puerarin
- 3
Studies by the year they started
5 studies that test it; most in 2013 (1)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
Chengdu PLA General Hospital (2) · The University of Hong Kong (1) · Ruijin Hospital (1) · Cairo University (1)
Studies
Open first, then newest update. How each study uses puerarin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- The Efficacy and Safety of Puerarin in Obesity TreatmentNot yet recruitingPhase 2Ruijin HospitalNCT06968208Written as Puerarin
- Effect of Puerarin on Heart Health in MenCompletedPhase 2The University of Hong KongNCT03676296Written as Puerarin
- The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid ArthritisCompletedPhase 2Chengdu PLA General HospitalNCT02254655Written as Puerarin injection 400 mg
- Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic DiseasesStatus unknownNot applicableChengdu PLA General HospitalNCT02219191Written as puerarin tablet 50 mg
- Alveolar Cleft Grafting Using Two Different Alloplastic GraftsStatus unknownPhase 2Cairo UniversityNCT03016793Written as Puerarin
As the comparator · 1 — what is tested is compared with puerarin
Codes
What other systems call puerarin · ClinicalTrials.gg INT003010
- MeSH (NLM) C033607puerarinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Z9W8997416PUERARINConfirmed NLM, Wikidata
- Wikidata Q4392082puerarinConfirmed NLM, Wikidata
- DrugBank DB12290One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C033607 | puerarin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Z9W8997416 | PUERARIN | Confirmed NLM, Wikidata |
| Wikidata | Q4392082 | puerarin | Confirmed NLM, Wikidata |
| DrugBank | DB12290 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.